<?xml version="1.0" encoding="UTF-8"?>
<p id="p0010" num="0010" sourceFile="EPÂ 1561463B1.xml">According to a first aspect, the present invention provides a compound which is a compound of Formula II or a pharmaceutically acceptable salt thereof: 
  <chemistry id="chem0001" num="0001">
    <img id="ib0001" file="imgb0001.tif" wi="127" he="46" img-content="chem" img-format="tif" orientation="portrait" inline="no"/>
  </chemistry> wherein: R
  <sub>1</sub> and R
  <sub>2</sub> are each independently selected from the group consisting of H, loweralkyl, oxyalkyl, alkoxyalkyl, cycloalkyl, aryl, hydroxyalkyl, aminoalkyl or alkylaminoalkyl; R
  <sub>3</sub> is H, loweralkyl, oxyalkyl, alkoxyalkyl, hydroxyalkyl, cycloalkyl, aryl, aminoalkyl, alkylaminoalkyl or halogen; R
  <sub>4</sub> is -OY, or R
  <sub>1</sub> and R
  <sub>4</sub> together represent 
  <chemistry id="chem0002" num="0002">
    <img id="ib0002" file="imgb0002.tif" wi="30" he="16" img-content="chem" img-format="tif" orientation="portrait" inline="no"/>
  </chemistry> wherein R
  <sub>5</sub> is 
  <chemistry id="chem0003" num="0003">
    <img id="ib0003" file="imgb0003.tif" wi="35" he="25" img-content="chem" img-format="tif" orientation="portrait" inline="no"/>
  </chemistry> Y is H or loweralkyl; n is an integer from 0 to 2; and A is a heterocyclic aromatic group selected from the group consisting of:
  <!-- EPO <DP n="4"> -->
  <chemistry id="chem0004" num="0004">
    <img id="ib0004" file="imgb0004.tif" wi="95" he="27" img-content="chem" img-format="tif" orientation="portrait" inline="no"/>
  </chemistry> wherein R
  <sub>6</sub> and R
  <sub>7</sub> are each independently selected from the group consisting of H, loweralkyl, halogen, oxyalkyl, oxyaryl, or oxyarylalkyl.
</p>
